| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $97,713,407 ) (Continued on the next page) |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | K23HD110435 | Neurobiology of hormonal contraception | 000 | 3 | NIH | 1/20/2025 | $160,801 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DE033098 | The role of GATA3 in hemifacial microsomia | 000 | 2 | NIH | 1/14/2025 | $357,250 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL136636 | Capillary control of cerebral blood flow, and its disruption in small vessel disease | 000 | 9 | NIH | 2/14/2025 | $427,250 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | U01DK134981 | Understanding the Pathophysiology of Type 2 Diabetes in Navajo Youth | 001 | 3 | NIH | 2/17/2025 | $693,197 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | U01DK134958 | What Activates Type 2 diabetes in Children (WATCH) | 000 | 3 | NIH | 2/14/2025 | $566,914 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21HL177693 | Secondary Analysis of 3D Echo Images of the Right Ventricle to Compute 3D Surface Strain | 000 | 1 | NIH | 3/10/2025 | $117,000 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL169473 | Extracellular matrix turnover in pathological cardiac remodeling | 000 | 2 | NIH | 3/4/2025 | $524,090 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL161004 | The paradoxical response to iron in pulmonary hypertension of sickle cell disease | 000 | 4 | NIH | 3/10/2025 | $600,149 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21AI190731 | Streptococcus pneumoniae HtrA and its target interactions | 000 | 1 | NIH | 2/28/2025 | $189,150 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HD079404 | Regulation of Fetal Skeletal Muscle Growth in IUGR | 000 | 9 | NIH | 2/14/2025 | $576,531 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HD079404 | Regulation of Fetal Skeletal Muscle Growth in IUGR | 001 | 9 | NIH | 4/17/2025 | $64,059 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21HL177785 | Hemostatic erythrocytes for acute non-compressible hemorrhage | 000 | 1 | NIH | 2/24/2025 | $234,000 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DE030683 | Targeting oncogenic Myb fusions in salivary gland cancer with the elongation inhibitor SVC112 | 000 | 5 | NIH | 3/7/2025 | $448,104 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA239093 | Discovery and therapeutic targeting of biological determinants of lung cancer health disparities | 000 | 6 | NIH | 2/14/2025 | $389,804 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DC021865 | The role of Kit signaling in taste bud regeneration | 000 | 2 | NIH | 2/21/2025 | $537,451 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA301643 | Role of respiratory viral infections and inflammation in promoting metastatic outgrowth in the lung | 000 | 1 | NIH | 2/27/2025 | $672,011 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31AG084295 | Individual Predoctoral Fellowship | 000 | 2 | NIH | 2/14/2025 | $36,577 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01AG065259 | Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease | 000 | 5 | NIH | 2/14/2025 | $379,687 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01NS115975 | The role of myelination in cortical circuit function and motor behavior | 000 | 6 | NIH | 1/31/2025 | $571,444 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DA042755 | The Effects of Cannabis Legalization and Persistent Use: A Longitudinal Study of Two Twin Cohorts | 003 | 7 | NIH | 4/3/2025 | $1,478,674 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK138960 | Role of the Factor H Related Proteins in Kidney Disease | 000 | 2 | NIH | 3/4/2025 | $481,125 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | U01NS114312 | Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement | 002 | 5 | NIH | 2/14/2025 | $77,998 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | U01NS114312 | Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement | 001 | 5 | NIH | 2/13/2025 | $782,432 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R35GM133433 | Understanding the variability in nonsense-mediated RNA decay | 001 | 6 | NIH | 1/31/2025 | $417,177 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31HL165967 | Epicardial Adipose Tissue and Cardiometabolic Risk Factors in Youth-Onset Type 2 Diabetes Undergoing Bariatric Surgery | 000 | 2 | NIH | 1/22/2025 | $36,908 |
| | 2025 | 2025 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31DE032592 | Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma | 000 | 3 | NIH | 10/29/2024 | $45,294 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | K99CA287061 | Integration of multi-omics to predict and evaluate response during optimization of a nutrition intervention for cancer survivors with overweight and obesity | 000 | 2 | NIH | 1/28/2025 | $116,924 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL168686 | Mechanistic studies of human transporter Sialin | 000 | 2 | NIH | 4/7/2025 | $550,348 |
| | 2025 | 2025 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01AR051749 | Complement in the Pathogenesis of Autoimmune Arthritis | 000 | 19 | NIH | 11/27/2024 | $307,890 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F30AI160828 | Defining viral-host interactions between arthritogenic alphaviruses and MARCO | 000 | 4 | NIH | 12/11/2024 | $53,974 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | UG1CA233324 | NCI National Clinical Trials Network - Lead Academic Participant Sites | 000 | 6 | NIH | 3/13/2025 | $390,338 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DA058641 | Clinical Trial of Maternal Choline Supplements to Mitigate Effects of Prenatal Cannabis Exposure on Early Brain Development. | 001 | 2 | NIH | 4/10/2025 | $67,604 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DA058641 | Clinical Trial of Maternal Choline Supplements to Mitigate Effects of Prenatal Cannabis Exposure on Early Brain Development. | 000 | 2 | NIH | 2/26/2025 | $608,459 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01MD015122 | Modifiable factors in emergent presentation of potentially elective general surgical disease for patients who are insured or insurance-eligible | 002 | 5 | NIH | 4/18/2025 | $315,000 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21NS142950 | Understanding small molecule modulation of splicing for Huntington's disease therapy | 000 | 1 | NIH | 3/14/2025 | $195,000 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R00NS126642 | How do astrocytes remodel the nervous system? | 000 | 3 | NIH | 2/13/2025 | $224,100 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01AG066804 | Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits Intervention in Primary Care for Older Adults with and without Alzheimer's Dementia | 000 | 5 | NIH | 2/13/2025 | $633,215 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R25CA285225 | Training clinicians in the integration of technology with cancer supportive care | 000 | 2 | NIH | 2/12/2025 | $290,467 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R37CA254926 | Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening | 000 | 5 | NIH | 3/12/2025 | $566,615 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA282900 | A SIM2s/SEMA7A Switch Drives ER+ Breast Cancer Progression | 000 | 2 | NIH | 2/12/2025 | $490,937 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | K23HD114903 | TEEN LENS ED: TEen ENgaged LEthal meaNS planning for the Emergency Department | 000 | 2 | NIH | 3/20/2025 | $162,896 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | K08DK128544 | Impact of Aiolos on intestinal intraepithelial lymphocytes | 000 | 4 | NIH | 2/25/2025 | $161,920 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA279398 | The GPR171 pathway in cancer immunotherapy | 000 | 3 | NIH | 3/20/2025 | $320,136 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | K01HL157658 | The Contribution of Omic Profiles to Weight Loss and Obesity | 000 | 4 | NIH | 2/27/2025 | $158,790 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DE032681 | Data-driven quantification and prediction of pre-surgical local head volume distributions and post-surgical development in patients with craniosynostosis | 000 | 3 | NIH | 3/3/2025 | $359,592 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21CA280148 | Selective targeting of ependymoma progenitor cells via BMI1 inhibition | 000 | 2 | NIH | 2/13/2025 | $163,567 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA269221 | Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment | 000 | 3 | NIH | 3/5/2025 | $557,992 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01ES034042 | Air pollutants, heat exposure, and kidney health: A longitudinal study in women in Central America | 000 | 3 | NIH | 3/19/2025 | $590,989 |
| | 2025 | 2025 | THE REGENTS OF THE UNIV. OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DE030864 | Srsf3-mediated alternative RNA splicing in craniofacial development | 000 | 3 | NIH | 3/5/2025 | $449,883 |
|
